Dipeptidyl Peptidase-4 Inhibition: Linking Chemical Properties to Clinical Safety

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|18|31|4753-4760

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.31, 2011-11, pp. : 4753-4760

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dipeptidyl-peptidase 4 Inhibition: Linking Metabolic Control to Cardiovascular Protection

By  

Current Pharmaceutical Design, Vol. 20, Iss. 14, 2014-04 ,pp. : 2387-2394

Bentham Science Publishers

Access to resources Recommend Favorite

An Overview of Recent Dipeptidyl Peptidase-IV Inhibitors: Linking their Structure and Physico-Chemical Properties with SAR, Pharmacokinetics and Toxicity

By  

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 23, 2015-01 ,pp. : 2342-2372

Bentham Science Publishers

Access to resources Recommend Favorite

Vildagliptin: an inhibitor of dipeptidyl peptidase-4 with antidiabetic properties

By Ahrén Bo  

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 4, 2006-04 ,pp. : 431-442

Informa Healthcare

Access to resources Recommend Favorite

Medicinal Chemistry Approaches to the Inhibition of Dipeptidyl Peptidase IV

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 17, 2008-01 ,pp. : 1545-1552

Bentham Science Publishers

Access to resources Recommend Favorite

Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: comparison, efficacy and safety

By Deacon Carolyn F   Holst Jens J  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 15, 2013-10 ,pp. : 2047-2058

Informa Healthcare

Access to resources Recommend Favorite